Skip to main navigation Skip to search Skip to main content

A 52-Week, Multicenter, Open-Label Study to Evaluate the Efffectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients with Schizophrenia "ASPIRE OPEN-LABEL" (Aripiprazole Intramuscular Depot Program in Schizophren

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/09 → 12/31/10

Funding

  • Otsuka Pharmaceutical Development and Commercialization Inc